Dolby Laboratories (NYSE:DLB) EVP Mark Andrew Sherman Sells 4,500 Shares

Dolby Laboratories (NYSE:DLB) EVP Mark Andrew Sherman sold 4,500 shares of the firm’s stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price of $67.56, for a total transaction of $304,020.00. Following the completion of the sale, the executive vice president directly owned 62,397 shares in the company, valued at approximately $4,215,541.32. This trade represents a 6.73% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Dolby Laboratories Trading Down 0.0%

Shares of NYSE:DLB opened at $66.29 on Thursday. The company has a market capitalization of $6.33 billion, a PE ratio of 25.20 and a beta of 0.89. Dolby Laboratories has a twelve month low of $64.02 and a twelve month high of $89.66. The firm has a 50 day simple moving average of $67.80 and a 200-day simple moving average of $71.82.

Dolby Laboratories (NYSE:DLB) last released its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The business had revenue of $307.02 million for the quarter, compared to analyst estimates of $305.76 million. During the same quarter in the previous year, the company posted $0.61 earnings per share. The company’s revenue for the quarter was up .7% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. As a group, equities research analysts predict that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Dolby Laboratories Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd will be issued a $0.36 dividend. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date is Tuesday, December 2nd. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.2%. Dolby Laboratories’s dividend payout ratio (DPR) is 54.75%.

Institutional Trading of Dolby Laboratories

Hedge funds and other institutional investors have recently modified their holdings of the company. Allworth Financial LP lifted its holdings in shares of Dolby Laboratories by 99.6% during the 3rd quarter. Allworth Financial LP now owns 1,006 shares of the electronics maker’s stock valued at $73,000 after buying an additional 502 shares during the last quarter. Swiss Life Asset Management Ltd acquired a new stake in Dolby Laboratories in the third quarter valued at approximately $210,000. Advisory Services Network LLC bought a new stake in Dolby Laboratories in the third quarter worth approximately $102,000. XTX Topco Ltd acquired a new position in shares of Dolby Laboratories during the 3rd quarter worth $741,000. Finally, Verition Fund Management LLC raised its holdings in shares of Dolby Laboratories by 172.4% during the 3rd quarter. Verition Fund Management LLC now owns 35,409 shares of the electronics maker’s stock valued at $2,563,000 after purchasing an additional 22,409 shares in the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Robert W. Baird started coverage on Dolby Laboratories in a report on Friday, September 5th. They set a “neutral” rating and a $74.00 price objective on the stock. Rosenblatt Securities cut their price objective on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Wednesday, November 19th. Barrington Research reduced their price target on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research report on Wednesday, November 19th. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Finally, Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Three research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $92.00.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.